Literature DB >> 35970951

Dual-chamber ICD for left bundle branch area pacing: the cardiac resynchronization and arrhythmia sensing via the left bundle (cross-left) pilot study.

Nicolas Clementy1, Alexandre Bodin2, Vincent Ah-Fat2, Dominique Babuty2, Arnaud Bisson2.   

Abstract

BACKGROUND: Left bundle branch area pacing (LBBAP) has emerged as a promising technique to deliver cardiac resynchronization therapy (CRT). However, safety and efficacy of ventricular arrhythmia sensing via the left bundle in implantable cardioverter-defibrillator (ICD) recipients remain unclear. We sought to evaluate the feasibility of a single LBBAP lead connected to a dual-chamber ICD in patients indicated with a CRT-D implantation.
METHODS: The CROSS-LEFT pilot study prospectively included 10 consecutive patients with a reduced ejection fraction and a complete left bundle branch block, indicated with a prophylactic CRT-D. A DF-1 lead was implanted at the right ventricular (RV) apex, and an LBBAP lead through the interventricular septum. Ventricular fibrillation was induced at implantation in both conventional (RV) and left bundle branch area sensing configurations. The latter was the final sensing configuration, and patients were implanted with a dual-chamber DF-1 ICD connected to the atrial lead (RA port), the LBBAP lead (RV IS-1 port), and the defibrillation lead (RV DF-1 port), the IS-1 pin being capped. Atrioventricular delay was optimized to ensure fusion between LBBAP and native conduction from the right bundle. Patients were followed during 6 months.
RESULTS: No difference between both configurations was observed regarding R-wave sensing in sinus rhythm (p = 0.22), ventricular fibrillation median interval detection (p = 1.00), or total induced episode duration (p = 0.78). LBBAP resulted in a significant reduction of median QRS width from 164 to 126 ms (p = 0.002). Median ventricular sensing significantly improved from 9.7 at implantation to 18.8 mV at 6 months (p = 0.01). Median LVEF also significantly improved from 29 to 44% at 6 months (p = 0.002).
CONCLUSION: Ventricular arrhythmia sensing and defibrillation can be performed via a single LBBAP lead connected to a dual-chamber ICD, and is associated with significant electromechanical reverse remodeling. CLINICAL TRIAL REGISTRATION NUMBER: NCT05102227 In patients presenting with left bundle branch block and left ventricular systolic dysfunction, a left bundle branch area pacing lead connected to a DF-1 dual-chamber implantable cardioverter-defibrillator provides safe ventricular arrhythmia sensing and efficient electro-mechanical resynchronization.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cardiac resynchronization therapy; Heart failure; Implantable cardioverter defibrillator; Left bundle branch area pacing; Sensing

Year:  2022        PMID: 35970951     DOI: 10.1007/s10840-022-01342-6

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.759


  12 in total

1.  A beginner's guide to permanent left bundle branch pacing.

Authors:  Weijian Huang; Xueying Chen; Lan Su; Shengjie Wu; Xue Xia; Pugazhendhi Vijayaraman
Journal:  Heart Rhythm       Date:  2019-06-22       Impact factor: 6.343

2.  Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial.

Authors:  Alfred E Buxton; Kerry L Lee; Gail E Hafley; D George Wyse; John D Fisher; Michael H Lehmann; Luis A Pires; Michael R Gold; Douglas L Packer; Mark E Josephson; Eric N Prystowsky; Mario R Talajic
Journal:  Circulation       Date:  2002-11-05       Impact factor: 29.690

3.  Physiological pacing with a DF-1 single chamber defibrillator in a patient with permanent atrial fibrillation and heart block: A case report.

Authors:  Mathieu Nasarre; Nicolas Clementy; Alexandre Bodin; Dominique Babuty; Arnaud Bisson
Journal:  J Cardiovasc Electrophysiol       Date:  2022-03-08

4.  Catheter ablation vs. antiarrhythmic drugs as 'first-line' initial therapy for atrial fibrillation: a pooled analysis of randomized data.

Authors:  Shaojie Chen; Helmut Pürerfellner; Feifan Ouyang; Márcio Galindo Kiuchi; Christian Meyer; Martin Martinek; Piotr Futyma; Lin Zhu; Alexandra Schratter; Jiazhi Wang; Willem-Jan Acou; Zhiyu Ling; Yuehui Yin; Shaowen Liu; Philipp Sommer; Boris Schmidt; Julian K R Chun
Journal:  Europace       Date:  2021-12-07       Impact factor: 5.214

5.  Effect of acute and chronic ethanol on atrial fibrillation vulnerability in rats.

Authors:  Hao Zhang; Hongmei Ruan; Dolkun Rahmutula; Emily Wilson; Gregory M Marcus; Vasanth Vedantham; Jeffrey E Olgin
Journal:  Heart Rhythm       Date:  2019-11-20       Impact factor: 6.343

6.  Calmodulin kinase II regulates atrial myocyte late sodium current, calcium handling, and atrial arrhythmia.

Authors:  Amara Greer-Short; Hassan Musa; Katherina M Alsina; Li Ni; Tarah A Word; Julia O Reynolds; Daniel Gratz; Cemantha Lane; Mona El-Refaey; Sathya Unudurthi; Michel Skaf; Ning Li; Vadim V Fedorov; Xander H T Wehrens; Peter J Mohler; Thomas J Hund
Journal:  Heart Rhythm       Date:  2019-10-14       Impact factor: 6.343

7.  Effects of 60-Hertz notch filtering on local abnormal ventricular activities.

Authors:  Xiaoxiong Zhou; Yunqiu Jiang; Daniel Sohinki; Wei Liu; Sunny S Po
Journal:  Heart Rhythm       Date:  2020-09-08       Impact factor: 6.343

8.  Left bundle branch-optimized cardiac resynchronization therapy (LOT-CRT): Results from an international LBBAP collaborative study group.

Authors:  Marek Jastrzębski; Paweł Moskal; Wim Huybrechts; Karol Curila; Praveen Sreekumar; Leonard M Rademakers; Shunmuga Sundaram Ponnusamy; Bengt Herweg; Parikshit S Sharma; Agnieszka Bednarek; Marek Rajzer; Pugazhendhi Vijayaraman
Journal:  Heart Rhythm       Date:  2021-07-30       Impact factor: 6.343

9.  Magnetic Resonance Imaging in Patients With Cardiac Implantable Electronic Devices With Abandoned Leads.

Authors:  Robert D Schaller; Tamara Brunker; Michael P Riley; Francis E Marchlinski; Saman Nazarian; Harold Litt
Journal:  JAMA Cardiol       Date:  2021-05-01       Impact factor: 14.676

Review 10.  Remote monitoring and telemedicine in heart failure: implementation and benefits.

Authors:  Jacopo Francesco Imberti; Alberto Tosetti; Davide Antonio Mei; Anna Maisano; Giuseppe Boriani
Journal:  Curr Cardiol Rep       Date:  2021-05-07       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.